Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer Treatment

Inclusion Criteria:

* Patient with invasive or pre-invasive (in situ) breast cancer, planned for immediate breast reconstruction post-skin sparing or nipple sparing mastectomy (unilateral or bilateral)
* Patient agrees to participate in study and to sign an informed consent form
* Able and willing to return for all scheduled and required study visits

Exclusion Criteria:

* Is a smoker (patient having quit at least 4 weeks prior surgery can be included)
* BMI \<18 or \> 30
* Previous radiation therapy to the region at any time
* Insulin-dependent diabetes or any immune deficiency requiring immunosuppressant use such as cortisone or biological therapies
* Predicted implant size \<200 or \>600 ml per investigator assessment
* Allergy to porcine
* Pregnancy or lactating
* Current enrollment or plans to enroll in another clinical trial unless a retrospective study
* Neoadjuvant treatment with chemotherapy